Skip to main content

Fiscal Wizard · Single-issue tearsheet

LKFT / Jun 21, 2026 Run #7423

LKFT

Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Composite verdict

D 38.1 / 100
Bearish setup · Mean Reversion 9 drivers · 2 gates blocking
  • Accumulation/Distribution Line
  • Stochastic Cross
  • Bollinger Reentry
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 120th of 598 in Biotechnology

rescore-sweep
Technical synthesisRegime: range
Bull 0%Evidence: High · 22 signals100% Bear
Momentum Bearish 39Mean-reversion Bearish 13

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from
Asset value $49.13Earnings power value $68.06Price $28.30

Trading below its asset value ($49.13/share) — deep value, but check for a melting balance sheet.

Fundamentals Strong

75.2 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Cash Conversion Cycle 100
OCF to Net Income 0
Days Sales Outstanding 100
Free Cash Flow Yield 0
Earnings Yield 100
Cash Conversion 0

Technicals Bearish

0.9 / 100

Bearish setup leads (Accumulation/Distribution Line, Stochastic Cross, Bollinger Reentry); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Accumulation/Distribution Line 8
Bollinger Reentry 13
Stochastic Cross 14

Risk Gates

2 blocking 4 caution

2 guards active, 20 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Quick Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for LKFT.